<DOC>
	<DOCNO>NCT01413958</DOCNO>
	<brief_summary>This study compare nasal congestion symptom relief phenylephrine extend release tablet placebo participant allergic rhinitis .</brief_summary>
	<brief_title>Effects Phenylephrine Extended-Release Tablets Allergy-Related Nasal Congestion ( P08498 AM1 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Understands study procedure agree participate give signed consent form Male female , age 18 year old , Screening Visit . Female participant must demonstrate negative urine pregnancy test , Screening ( Visit 1 ) Visit 2 ( prior randomization ) agree use ( and/or partner use ) 2 acceptable method birth control begin Screening visit throughout study 2 week last dose study drug last treatment period . Acceptable method birth control abstinence , two following : hormonal contraceptive ( document use least 30 day prior Screening ) intrauterine device ( IUD ) diaphragm spermicide contraceptive sponge condom vasectomy Willing stop use current decongestant allergy medication trial Documented selfreported history allergic rhinitis cause fall pollen within last 4 year document selfreported symptom least last 2 fall allergy season Documented skin testing ( prick wheal ≥3 mm large diluent intradermal wheal ≥7 mm large diluent control ) within last 4 year fall pollen allergen present prevalent his/her geographic region . Signs symptoms nasal congestion ( define stuffy block nose ) least mild severity ( sign/symptom clearly present , minimal awareness ; easily tolerate ) follow washout period ( applicable ) . Participant 's diary evaluation must document least mild symptom reflective instantaneous score 4 consecutive day prior randomization . Mean seat ( 5 minute rest ) systolic/diastolic blood pressure ≤ 138/88 mmHg . Clinically acceptable physical exam 12lead ECG ( record 25 mm/s ) clinically acceptable investigator . Free clinically significant disease require physician 's care and/or would interfere trial evaluation , procedure , participation . Agrees take monoamine oxidase inhibitor ( MAOIs ) 14 day trial participation 14 day last dose study drug . Capable read English . Significant medical condition contraindication use phenylephrine , might interfere trial , require treatment expect affect blood pressure History presence hypertension Started allergen immunotherapy within 1 month enrollment , start immunotherapy trial , anticipate immunotherapy dose change trial Used Xolair ( omalizumab ) within 4 year prior trial participation Known allergy intolerance phenylephrine , loratadine , desloratadine History rhinitis medicamentosa Documented evidence acute significant chronic sinusitis Clinically significant nasal disorder deviate septum nasal polyposis Asthma , exception mild intermittent asthma Have use systemic ( oral , rectal , injectable ) , topical ( 1 % topical hydrocortisone permit ) , nasal corticosteroid last 30 day Mentally legally incapacitate , significant emotional problem time Screening Visit expect conduct study , history clinically significant psychiatric disorder last 5 year . Those situational depression may enrol study discretion investigator . History illness , opinion study investigator , might confound result study pose additional risk participant participation study . History immunological disease cancer within past 5 year , exception nonmelanoma skin cancer Positive drug screen ( participant prescribe medication result positive drug screen result may still enrol discretion investigator ) . Major surgery participation another investigational study within 30 day prior Screening Visit . Body mass index ( BMI ) ≥ 40</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Nasal Decongestants</keyword>
	<keyword>Rhinitis , Allergic , Seasonal</keyword>
	<keyword>Rhinitis</keyword>
	<keyword>Nose Conditions</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Phenylephrine</keyword>
</DOC>